Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Onpharma is a medical technology company that specializes in the development of advanced local anesthetic delivery systems for the dental industry. The company's core innovation is the Onset technology, a point-of-care buffering system that allows dental professionals to adjust the pH of local anesthetics immediately before administration. By neutralizing the acidity of traditional anesthetic solutions, Onset facilitates a faster transition to the active base form of the drug, leading to more rapid pulpal anesthesia and reduced injection pain. This technology aims to improve clinical efficiency by decreasing patient waiting times and increasing the predictability of anesthetic success. Onpharma was acquired by Sextant in 2014 and continues to provide its buffering solutions to the global dental market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Onpharma.